ES2053979T3 - Derivados de tetralina terapeuticamente utiles. - Google Patents

Derivados de tetralina terapeuticamente utiles.

Info

Publication number
ES2053979T3
ES2053979T3 ES89302533T ES89302533T ES2053979T3 ES 2053979 T3 ES2053979 T3 ES 2053979T3 ES 89302533 T ES89302533 T ES 89302533T ES 89302533 T ES89302533 T ES 89302533T ES 2053979 T3 ES2053979 T3 ES 2053979T3
Authority
ES
Spain
Prior art keywords
alkyl
cycloalkyl
therapeutically useful
thiophene
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89302533T
Other languages
English (en)
Inventor
Bengt Ronny Andersson
Per Arvid Emil Carlsson
Kjell Anders Ivan Svensson
Hakan Vilhelm Wikstrom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ES2053979T3 publication Critical patent/ES2053979T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/31—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/38—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with the sulfur atom of the thio group bound to a carbon atom of a six-membered aromatic ring being part of a condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

ESTA INVENCION SE REFIERE A TETRALINAS TERAPEUTICAMENTE UTILES Y A SUS SALES DE ADICION DE ACIDO FARMACEUTICAMENTE ACEPTABLES, DE FORMULA (I) EN LA QUE - YR1 ES UN SUSTITUYENTE EN LA POSICION 5, 6, 7 O 8 DEL ANILLO AROMATICO Y ES - S ALQUILO (DE 1 A 3C) O OR1 (EN EL QUE R1 SE SELECCIONA DEL GRUPO FORMADO POR ALQUILO, ALQUENILO, - CH2 - CICLOALQUILO O BENCILO TENIENDO TODOS LOS ALQUILOS Y ALQUENILO HASTA 8C); R2 ES H O ALQUILO DE 1 A 3C; R3 ES - CH2 - CICLOALQUILO (DE 3 A 8C); R4 ES H, ALQUILO DE (1 A 8C), - CH2 - CICLOALQUILO (DE 3 O 4C) - (CH2)M - R5 O - CH2 - CH2 - X - (CH2)N CH3 (DONDE N VALE DE 0 A 3 Y M VALE 2 O 3, X ES O O S Y R5 ES FENILO QUE PUEDE ESTAR SUSTITUIDO CON UNO O DOS SUSTITUYENTES SELECCIONADOS DE CLORO, BROMO, FLUOR, ALCOXI O ALQUILO DE 1 A 3C, 2 - TIOFENO O 3 - TIOFENO, CON LA CONDICION DE QUE CUANDO R3 CONTIENE MAS DE 4 ATOMOS DE C Y R4 ES ALQUILO, DICHO ALQUILO CONTIENE DE 1 A 3C).
ES89302533T 1988-03-25 1989-03-15 Derivados de tetralina terapeuticamente utiles. Expired - Lifetime ES2053979T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17313088A 1988-03-25 1988-03-25

Publications (1)

Publication Number Publication Date
ES2053979T3 true ES2053979T3 (es) 1994-08-01

Family

ID=22630664

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89302533T Expired - Lifetime ES2053979T3 (es) 1988-03-25 1989-03-15 Derivados de tetralina terapeuticamente utiles.

Country Status (14)

Country Link
EP (2) EP0407416A1 (es)
JP (1) JP2750187B2 (es)
KR (1) KR970005323B1 (es)
AT (1) ATE82954T1 (es)
AU (1) AU616253B2 (es)
CA (1) CA1331191C (es)
DE (1) DE68903659T2 (es)
DK (1) DK223490A (es)
ES (1) ES2053979T3 (es)
FI (1) FI102893B (es)
GR (1) GR3006983T3 (es)
NZ (1) NZ228392A (es)
WO (1) WO1989009050A1 (es)
ZA (1) ZA891903B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA899033B (en) * 1988-12-01 1990-09-26 Merrell Dow Pharma Phenoxy and phenylthio,amino substituted benzocycloalkane derivatives in the treatment and prevention of drug-resistant protozoal infections
IL114715A (en) * 1989-02-27 1997-01-10 Lilly Co Eli Intermediate compounds for ring-substituted 2-amino-1, 2, 3, 4-tetrahydronaphthalenes and 3-aminochromanes
RU2086535C1 (ru) * 1989-05-31 1997-08-10 Дзе Апджон Компани Производные 1,2,3,4-тетрагидро-2-нафтиламина
US5071875A (en) * 1989-09-25 1991-12-10 Northwestern University Substituted 2-amidotetralins as melatonin agonists and antagonists
SE8904127D0 (sv) * 1989-12-07 1989-12-07 Astra Ab New biocyclic amino-substituted compounds
FR2659853A1 (fr) * 1990-03-22 1991-09-27 Midy Spa Utilisation de derives 2-aminotetraliniques pour la preparation de medicaments destines a combattre les troubles de la motricite intestinale.
EP0450238A1 (en) * 1990-03-30 1991-10-09 Merrell Dow Pharmaceuticals Inc. Novel compounds for the treatment of migraine
US5258379A (en) * 1990-05-04 1993-11-02 Eli Lilly And Company Method of inhibiting gastric acid secretion with n-arylpiperazines
US5096908A (en) * 1990-05-04 1992-03-17 Eli Lilly And Company Method of inhibiting gastric acid secretion
DK0471515T3 (da) * 1990-08-15 1997-07-21 Lilly Co Eli Ringsubstituerede 2-amino-1,2,3,4-tetrahydronphtalener, 3-aminochromaner og 3-aminothiochromaner
IT1251877B (it) * 1991-09-26 1995-05-26 Zambon Spa Processo per la preparazione di 2-ammino-5,6 dimetossi-tetralina
JP3100005B2 (ja) * 1992-07-28 2000-10-16 雪印乳業株式会社 ヒト免疫不全ウィルス感染・増殖抑制剤
DK0712387T3 (da) * 1993-08-06 2000-05-29 Upjohn Co 2-Aminoindaner som selektive dopamin-D3-ligander
ES2235521T3 (es) 1998-10-07 2005-07-01 Ortho-Mcneil Pharmaceutical, Inc. N-aralquilaminotetralina como ligando para el neuropeptido y el receptor y5.
WO2001055107A2 (en) * 2000-01-28 2001-08-02 Melacure Therapeutics Ab Aromatic amines and amides acting on the melanocortin receptors
JP4353803B2 (ja) 2001-12-03 2009-10-28 エフ．ホフマン−ラ ロシュ アーゲー ムスカリン受容体アンタゴニストとしての４−ピペリジニルアルキルアミン誘導体
WO2003048125A1 (en) 2001-12-03 2003-06-12 F. Hoffmann-La Roche Ag Aminotetralin derivatives as muscarinic receptor antagonists
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1017359A (en) 1972-07-03 1977-09-13 Frederic P. Hauck Substituted cyclic polymethylene phenols
JPS5124508B2 (es) 1972-08-14 1976-07-24
DE2752659A1 (de) 1976-12-07 1978-06-08 Sandoz Ag Neue tetralinderivate, ihre herstellung und verwendung
CH637363A5 (en) 1977-11-24 1983-07-29 Sandoz Ag Process for preparing novel 2-aminotetralins
DE2803582A1 (de) 1978-01-27 1979-08-02 Sandoz Ag Neue tetralinderivate, ihre herstellung und verwendung
ZA825142B (en) 1981-07-23 1983-04-27 Erba Farmitalia N-imidazolyl derivatives of 1,2,3,j-tetrahydro-naphthalene, indan and 2-substituted-1-chroman, and process for their preparation
DE3479314D1 (en) * 1984-05-22 1989-09-14 Nelson Res & Dev Substituted 2-aminotetralins and processes for synthesis
IL79323A (en) * 1985-07-10 1990-03-19 Sanofi Sa Phenylethanolaminotetralines,their preparation and pharmaceutical compositions containing them
AU6548286A (en) * 1985-10-04 1987-04-24 Maggioni-Winthrop S.P.A. Fused cycloaliphatic aminoalcohols
DE3718317A1 (de) * 1986-12-10 1988-06-16 Bayer Ag Substituierte basische 2-aminotetraline
DE3719924A1 (de) 1986-12-22 1988-06-30 Bayer Ag 8-substituierte 2-aminotetraline

Also Published As

Publication number Publication date
GR3006983T3 (es) 1993-06-30
ATE82954T1 (de) 1992-12-15
AU616253B2 (en) 1991-10-24
DE68903659T2 (de) 1993-04-22
FI102893B1 (fi) 1999-03-15
KR970005323B1 (ko) 1997-04-15
JP2750187B2 (ja) 1998-05-13
DK223490D0 (da) 1990-09-17
FI102893B (fi) 1999-03-15
FI904696A0 (fi) 1990-09-24
NZ228392A (en) 1991-11-26
EP0334538B1 (en) 1992-12-02
ZA891903B (en) 1989-11-29
DK223490A (da) 1990-09-17
KR900700088A (ko) 1990-08-11
JPH03503411A (ja) 1991-08-01
CA1331191C (en) 1994-08-02
AU3284689A (en) 1989-10-16
DE68903659D1 (de) 1993-01-14
WO1989009050A1 (en) 1989-10-05
EP0407416A1 (en) 1991-01-16
EP0334538A1 (en) 1989-09-27

Similar Documents

Publication Publication Date Title
ES2053979T3 (es) Derivados de tetralina terapeuticamente utiles.
DK0636622T3 (da) Isoxazolderivater samt deres anvendelse som herbicider
ATE132134T1 (de) Benzamide
YU74792A (sh) Herbicidi
ES2062974T3 (es) Compuestos de cefalosporina, procedimientos para su preparacion y agentes antibacterianos.
BR8907772A (pt) Composto,processo de controle de vegetacao indesejavel e composicao herbicida
DK0452390T3 (da) Halogensubstituerede aminotetraliner
ATE124697T1 (de) Azabicyclische derivate mit affinität am muskarine rezeptor.
ES2130125T3 (es) 3-(1-tiazolidinilbutil-4-piperazinil)-1h-indazoles, un procedimiento para su preparacion y su uso como medicamentos.
ATE163649T1 (de) Peptide, herstellung und deren verwendung
FI853685A0 (fi) Nya n-alk(en)yl-n-(o,o-disubstituerade -tiofosforyl)-n'n'-disubstituerade glycinamider, foerfarande foer framstaellning av dessa samt kvalstergifter, insektgifter och svampgifter vilka innehaoller dessa som aktiv bestaondsdel.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 334538

Country of ref document: ES